Many previous studies [65–67] have already demonstrated its up-regulation in CRC patients relative to controls, however, none of these studies generalized CXCL8 in CRC patients of different clinicopathological features (different races, cancer stages, genders, age groups, and body weights). The gene discussed is CXCL8; the disease is cancer.